Literature DB >> 10376618

Decline in total serum IgE after treatment for tuberculosis.

J F Adams1, E H Schölvinck, R P Gie, P C Potter, N Beyers, A D Beyers.   

Abstract

BACKGROUND: Infection with Mycobacterium tuberculosis induces a type-1 immune response, whereas intestinal parasites elicit a type-2 response. Given that type-1 and type-2 responses inhibit each other, we investigated if M tuberculosis downregulates serum IgE, a marker of a type-2 response.
METHODS: A prospective study was done in the Western Cape Province of South Africa, where tuberculosis and intestinal-parasite infection are common. Total serum IgE was determined for 37 controls and for 33 adolescent patients at presentation with tuberculosis and after successful completion of treatment. IgE specific for ascaris and allergens were measured in a subset of these individuals. Mantoux skin tests were done on 35 controls and on 31 patients at diagnosis.
FINDINGS: Total IgE concentrations were high in controls (mean 313 kU/L) and in patients before treatment (mean 457 kU/L, p=0.085) and declined in all patients following successful treatment (mean 175 kU/L, p<0.0001). Posttreatment IgE concentrations did not differ from concentrations in controls. Ascaris-specific IgE was lower in controls (mean 1.73 kU/L) than in patients before treatment (4.62 kU/L, p=0.023) and was 2.39 kU/L in patients after treatment (p=0.0625). Tuberculin induration correlated inversely with IgE in patients but not in controls.
INTERPRETATION: Infection with M tuberculosis as such is not incompatible with a prominent IgE response. IgE concentrations decreased after successful treatment of tuberculosis, showing that IgE concentrations in human beings can be downregulated under these circumstances, presumably due to enhancement of a type-1 response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376618     DOI: 10.1016/s0140-6736(98)08510-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Serological markers of disease activity in tuberculosis and HIV infection.

Authors:  A Marchant
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Cytokine polarization in miliary and pleural tuberculosis.

Authors:  Surendra K Sharma; Dipender K Mitra; Arumugam Balamurugan; Ravindra M Pandey; Narinder K Mehra
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

3.  Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.

Authors:  F Qadri; M Asaduzzaman; C Wennerås; G Mohi; M J Albert; M Abdus Salam; R B Sack; M Jertborn; J R McGhee; D A Sack; J Holmgren
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies.

Authors:  Gregory D Hussey; Marcia L V Watkins; Elizabeth A Goddard; Sean Gottschalk; Elizabeth J Hughes; Karen Iloni; Maurice A Kibel; Stanley R Ress
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Pulmonary tuberculosis and serum IgE.

Authors:  T Ohrui; K Zayasu; E Sato; T Matsui; K Sekizawa; H Sasaki
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 6.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Serum IgE levels of tuberculosis patients in a tropical setup with high prevalence of HIV and intestinal parasitoses.

Authors:  A Kassu; A Mohammad; Y Fujimaki; F Moges; D Elias; F Mekonnen; G Mengistu; M Yamato; Y Wondmikun; F Ota
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review.

Authors:  Juan M Cubillos-Angulo; Catarina D Fernandes; Davi N Araújo; Cristinna A Carmo; María B Arriaga; Bruno B Andrade
Journal:  Syst Rev       Date:  2021-06-09

9.  Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.

Authors:  Linda K Ellertsen; Dag G Storla; Lien M Diep; Karl A Brokstad; Harald G Wiker; Geir Hetland
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

10.  Allergic disorders in Africa and africans: is it primarily a priority?

Authors:  Erasto Vitus Mbugi; Jaffu Othniel Chilongola
Journal:  World Allergy Organ J       Date:  2010-05-07       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.